Russell Investments Group Ltd. increased its position in Agilent Technologies, Inc. (NYSE:A - Free Report) by 55.8% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 501,933 shares of the medical research company's stock after purchasing an additional 179,709 shares during the quarter. Russell Investments Group Ltd. owned approximately 0.18% of Agilent Technologies worth $58,710,000 as of its most recent SEC filing.
Several other hedge funds have also bought and sold shares of the company. Mirae Asset Global Investments Co. Ltd. raised its position in shares of Agilent Technologies by 13.5% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 36,674 shares of the medical research company's stock valued at $4,279,000 after buying an additional 4,362 shares in the last quarter. Assenagon Asset Management S.A. raised its position in Agilent Technologies by 8.3% during the first quarter. Assenagon Asset Management S.A. now owns 30,827 shares of the medical research company's stock valued at $3,606,000 after purchasing an additional 2,371 shares in the last quarter. Alps Advisors Inc. boosted its holdings in shares of Agilent Technologies by 29.5% in the 1st quarter. Alps Advisors Inc. now owns 13,358 shares of the medical research company's stock valued at $1,563,000 after purchasing an additional 3,040 shares in the last quarter. D.A. Davidson & CO. raised its holdings in shares of Agilent Technologies by 30.4% during the 1st quarter. D.A. Davidson & CO. now owns 9,474 shares of the medical research company's stock worth $1,108,000 after buying an additional 2,207 shares in the last quarter. Finally, Live Oak Investment Partners bought a new position in Agilent Technologies in the first quarter valued at about $603,000. 87.41% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently weighed in on the stock. Leerink Partners raised their price target on shares of Agilent Technologies to $135.00 and gave the company a "buy" rating in a research note on Friday, May 30th. UBS Group dropped their price objective on shares of Agilent Technologies from $150.00 to $130.00 and set a "neutral" rating for the company in a research note on Thursday, May 29th. JPMorgan Chase & Co. lowered their price target on shares of Agilent Technologies from $160.00 to $155.00 and set an "overweight" rating for the company in a report on Thursday, May 29th. Jefferies Financial Group cut their price objective on Agilent Technologies from $135.00 to $116.00 and set a "hold" rating on the stock in a report on Monday, April 21st. Finally, Evercore ISI upped their target price on Agilent Technologies from $125.00 to $130.00 and gave the stock an "in-line" rating in a report on Tuesday, July 8th. Six analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat, Agilent Technologies has an average rating of "Moderate Buy" and an average price target of $139.77.
Read Our Latest Stock Report on A
Insider Buying and Selling
In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,508 shares of the firm's stock in a transaction on Tuesday, July 1st. The shares were sold at an average price of $117.44, for a total value of $177,099.52. Following the completion of the transaction, the chief executive officer directly owned 37,448 shares of the company's stock, valued at $4,397,893.12. This trade represents a 3.87% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.26% of the stock is currently owned by corporate insiders.
Agilent Technologies Stock Up 0.4%
Shares of A stock traded up $0.43 on Friday, hitting $119.30. The stock had a trading volume of 1,238,463 shares, compared to its average volume of 1,437,926. The company has a debt-to-equity ratio of 0.55, a current ratio of 2.09 and a quick ratio of 1.60. The business has a 50 day moving average of $117.82 and a 200 day moving average of $118.31. Agilent Technologies, Inc. has a 12-month low of $96.43 and a 12-month high of $153.84. The stock has a market cap of $33.89 billion, a price-to-earnings ratio of 29.46, a price-to-earnings-growth ratio of 3.62 and a beta of 1.22.
Agilent Technologies (NYSE:A - Get Free Report) last posted its quarterly earnings data on Wednesday, May 28th. The medical research company reported $1.31 EPS for the quarter, beating the consensus estimate of $1.26 by $0.05. Agilent Technologies had a net margin of 17.59% and a return on equity of 25.92%. The firm had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.63 billion. During the same quarter last year, the business posted $1.22 EPS. The company's revenue for the quarter was up 6.0% on a year-over-year basis. As a group, analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current year.
Agilent Technologies Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Wednesday, July 23rd. Shareholders of record on Tuesday, July 1st were paid a $0.248 dividend. The ex-dividend date was Tuesday, July 1st. This represents a $0.99 annualized dividend and a yield of 0.8%. Agilent Technologies's dividend payout ratio (DPR) is currently 24.44%.
About Agilent Technologies
(
Free Report)
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Featured Articles
Before you consider Agilent Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilent Technologies wasn't on the list.
While Agilent Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access